These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 14534520

  • 1. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY, Kim KA, Park PW, Park CW, Shin JG.
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [Abstract] [Full Text] [Related]

  • 2. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Kang MH, Kim SL, Shin JG.
    Clin Pharmacol Ther; 2004 Mar; 75(3):157-62. PubMed ID: 15001966
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [Abstract] [Full Text] [Related]

  • 4. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C.
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [Abstract] [Full Text] [Related]

  • 5. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [Abstract] [Full Text] [Related]

  • 6. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K, Kivistö KT, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [Abstract] [Full Text] [Related]

  • 7. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [Abstract] [Full Text] [Related]

  • 8. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.
    Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2001 Jun; 69(6):400-6. PubMed ID: 11406737
    [Abstract] [Full Text] [Related]

  • 9. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
    Delrat P, Paraire M, Jochemsen R.
    Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789
    [Abstract] [Full Text] [Related]

  • 10. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [Abstract] [Full Text] [Related]

  • 11. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S, Chen XP, Cao D, Yin T, Dai ZY, Luo J, Tang L, Li YJ.
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [Abstract] [Full Text] [Related]

  • 12. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
    Jokinen MJ, Olkkola KT, Ahonen J, Neuvonen PJ.
    Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750
    [Abstract] [Full Text] [Related]

  • 13. Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone.
    Kim KA, Park PW, Liu KH, Kim KB, Lee HJ, Shin JG, Park JY.
    J Clin Pharmacol; 2008 Jan; 48(1):66-72. PubMed ID: 18094221
    [Abstract] [Full Text] [Related]

  • 14. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 15. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K, Hofmann U, Klotz U.
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [Abstract] [Full Text] [Related]

  • 16. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.
    Cho SK, Yoon JS, Lee MG, Lee DH, Lim LA, Park K, Park MS, Chung JY.
    Clin Pharmacol Ther; 2011 Mar; 89(3):416-21. PubMed ID: 21270793
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [Abstract] [Full Text] [Related]

  • 18. Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolam.
    Ujiie Y, Fukasawa T, Yasui-Furukori N, Suzuki A, Tateishi T, Otani K.
    Ther Drug Monit; 2006 Jun; 28(3):299-302. PubMed ID: 16778710
    [Abstract] [Full Text] [Related]

  • 19. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M, Kivistö KT, Backman JT, Neuvonen PJ.
    Br J Clin Pharmacol; 2000 Dec; 50(6):591-5. PubMed ID: 11136298
    [Abstract] [Full Text] [Related]

  • 20. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T, Kivistö KT, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.